CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma - Reply

被引：0
作者：
Doorduijn, JK [1 ]
Sonneveld, P [1 ]
机构：
[1] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 21期
关键词：
D O I：
10.1200/JCO.2005.014464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4799 / 4800
页数：2
相关论文
共 50 条
  • [41] CD64 surface expression on neutrophils and monocytes is significantly up-regulated after stimulation with granulocyte colony-stimulating factor during CHOP chemotherapy for patients with non-Hodgkin's lymphoma
    Kakinoki, Y
    Kubota, H
    Yamamoto, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (01) : 55 - 62
  • [42] Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma
    Limat, S.
    Daguindau, E.
    Cahn, J. -Y.
    Nerich, V.
    Brion, A.
    Perrin, S.
    Woronoff-Lemsi, M. -C.
    Deconinck, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (02) : 168 - 174
  • [43] Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma
    Burton, C
    Smith, P
    Vaughan-Hudson, G
    Qian, W
    Hoskin, P
    Cunningham, D
    Hancock, B
    Linch, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (04) : 536 - 541
  • [44] CD64 Surface Expression on Neutrophils and Monocytes Is Significantly Up-Regulated after Stimulation with Granulocyte Colony-Stimulating Factor during CHOP Chemotherapy for Patients with Non-Hodgkin’s Lymphoma
    Yasutaka Kakinoki
    Hiroya Kubota
    Yasushi Yamamoto
    International Journal of Hematology, 2004, 79 : 55 - 62
  • [45] Optimal dose of chop for treatment completion in elderly non-Hodgkin lymphoma patients
    Mori, M
    Murai, Y
    Suzuki, K
    Nonaka, Y
    Sato, H
    Tomiyama, J
    Takagi, T
    Muto, Y
    Kashimura, S
    BLOOD, 1995, 86 (10) : 3261 - 3261
  • [46] Phase I study of rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma
    Niitsu, N
    Hayama, M
    Okamoto, M
    Khori, M
    Higashihara, M
    Tamaru, J
    Hirano, M
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4077 - 4082
  • [47] Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck
    Tsuge, I
    Suzuki, K
    Moribe, K
    Motai, H
    Kimura, T
    Umeda, K
    Kobayashi, T
    Yokota, A
    Hondo, J
    Baba, S
    ACTA OTO-LARYNGOLOGICA, 1996, : 129 - 134
  • [48] Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma
    Chamorey, E
    Gressin, R
    Peyrade, F
    Rossi, JF
    Lepeu, G
    Foussard, C
    Harrousseau, JL
    Fabbro, M
    Richard, B
    Delwail, V
    Maisonneuve, H
    Vilque, JP
    Thyss, A
    ONCOLOGY, 2005, 69 (01) : 19 - 26
  • [49] Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report
    Micallef, Ivana N.
    Stiff, Patrick J.
    Nademanee, Auayporn P.
    Maziarz, Richard T.
    Horwitz, Mitchell E.
    Stadtmauer, Edward A.
    Kaufman, Jonathan L.
    McCarty, John M.
    Vargo, Rita
    Cheverton, Peter D.
    Struijs, Martin
    Bolwell, Brian
    DiPersio, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) : 1187 - 1195
  • [50] COMPARATIVE COST-EFFECTIVENESS OF PLERIXAFOR PLUS GRANULOCYTE-COLONY STIMULATING FACTOR VERSUS CYCLOPHOSPHAMIDE PLUS GRANULOCYTE-COLONY STIMULATING FOR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL MOBILIZATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
    Campen, C. J.
    Armstrong, E. P.
    Christian, J. A.
    Hadeed, S.
    Yeager, A. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S206 - S206
12345